|
1
|
Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
|
Mol Cell Proteomics
|
2004
|
1.57
|
|
2
|
Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions.
|
Mol Cell Proteomics
|
2005
|
1.32
|
|
3
|
Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
|
Mol Oncol
|
2009
|
1.07
|
|
4
|
Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.
|
Mol Cell Proteomics
|
2005
|
1.00
|
|
5
|
Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.
|
Mol Oncol
|
2009
|
0.99
|
|
6
|
Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker.
|
J Proteome Res
|
2010
|
0.93
|
|
7
|
Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment.
|
Philos Trans R Soc Lond B Biol Sci
|
2014
|
0.92
|
|
8
|
Contribution of Na+,HCO3(-)-cotransport to cellular pH control in human breast cancer: a role for the breast cancer susceptibility locus NBCn1 (SLC4A7).
|
Int J Cancer
|
2012
|
0.92
|
|
9
|
Tumor interstitial fluid - a treasure trove of cancer biomarkers.
|
Biochim Biophys Acta
|
2013
|
0.91
|
|
10
|
Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.
|
Mol Cell Proteomics
|
2012
|
0.91
|
|
11
|
Towards discovery-driven translational research in breast cancer.
|
FEBS J
|
2005
|
0.90
|
|
12
|
Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.
|
FEBS Lett
|
2006
|
0.89
|
|
13
|
A single lysis solution for the analysis of tissue samples by different proteomic technologies.
|
Mol Oncol
|
2008
|
0.88
|
|
14
|
15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma.
|
Mol Cell Proteomics
|
2008
|
0.88
|
|
15
|
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research.
|
Mol Cell Proteomics
|
2003
|
0.84
|
|
16
|
Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
|
Mol Oncol
|
2007
|
0.84
|
|
17
|
Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.
|
Mol Oncol
|
2007
|
0.79
|
|
18
|
Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.
|
Mol Cell Proteomics
|
2005
|
0.79
|
|
19
|
Immunoexpression analysis and prognostic value of BLCAP in breast cancer.
|
PLoS One
|
2012
|
0.78
|
|
20
|
Clinical proteomics.
|
Mol Cell Proteomics
|
2008
|
0.77
|
|
21
|
Proteomic strategies in bladder cancer: From tissue to fluid and back.
|
Proteomics Clin Appl
|
2008
|
0.76
|
|
22
|
Proteomic analysis of tissue samples in translational breast cancer research.
|
Expert Rev Proteomics
|
2014
|
0.75
|
|
23
|
Challenges and opportunities in oncoproteomics.
|
Mol Oncol
|
2010
|
0.75
|
|
24
|
Looking back, to go forward.
|
Mol Oncol
|
2014
|
0.75
|